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The gut microbiome is intimately related to human health, but it is not yet known which functional activities are driven by
specific microorganisms' ecological configurations or transcription. We report a large-scale investigation of 372 human faecal
metatranscriptomes and 929 metagenomes from a subset of 308 men in the Health Professionals Follow-Up Study. We identified a metatranscriptomic 'core' universally transcribed over time and across participants, often by different microorganisms.
In contrast to the housekeeping functions enriched in this core, a 'variable' metatranscriptome included specialized pathways
that were differentially expressed both across participants and among microorganisms. Finally, longitudinal metagenomic profiles allowed ecological interaction network reconstruction, which remained stable over the six-month timespan, as did strain
tracking within and between participants. These results provide an initial characterization of human faecal microbial ecology
into core, subject-specific, microorganism-specific and temporally variable transcription, and they differentiate metagenomically versus metatranscriptomically informative aspects of the human faecal microbiome.

A

lterations in the human gut microbiome have been implicated in a wide range of complex, chronic conditions, including inflammatory bowel disease (IBD), obesity, diabetes
mellitus, cancer and cardiovascular disease1,2. There is an appreciable body of work on the metagenomic potential of faecal communities3–6, yet little information is available regarding transcriptional
activity of the microbiome. The metatranscriptome represents a
link between the metagenome and community phenotype, and
surveying its molecular activity is important to understanding the
functional ecology of the human gut microbiome.
Metatranscriptomics has most commonly been applied to
ecological profiles of environmental microbial populations. For
instance, deep sequencing of marine bacterioplankton RNA established transcript inventories, uncovered gene expression trends
among metabolic generalists and specialists, and identified patterns
of substrate use and elemental cycling in the ocean ecosystem7.
Early human faecal metatranscriptomics suggested subject-specific relationships between microbiome transcripts and gene copy
number, differing across biological functions8. Our own pilot work
with the cohort studied here introduced protocols for integrating
metatranscriptomic sampling into large-scale epidemiological studies, demonstrating that metatranscriptional profiles are less variable than faecal taxonomic profiles but more individualized than
metagenomic function9.
However, previous studies have not surveyed the human faecal
metatranscriptome at sufficient scale to identify areas in which it is
uniquely informative relative to the underlying metagenome. It is
not yet clear, for example, which human conditions are associated

with specific microorganisms in the gut, versus their metagenomic
functional profiles, versus metatranscriptomic activity10. Cultureindependent faecal microbial transcription has been used in only a
few cases to date to identify causal mechanisms in health outcomes,
such as strain-specific variation in Eggerthella lenta expression
influencing the efficacy of cardiac therapy11. Integrated metagenomics and metatranscriptomics have also been used in molecular diagnostics for cancer risk and transplant rejection12. Correspondingly,
it remains to be determined what short-term or long-term healthlinked exposures can be assessed using faecal metagenomes or
metatranscriptomes in prospective cohorts.
To address these gaps, we interrogated the human faecal metagenome and metatranscriptome in 929 and 372 samples, respectively,
collected at up to four time points each from 308 healthy senior men
participating in the Men’s Lifestyle Validation Study (MLVS), nested
within the Health Professionals Follow-up Study (HPFS)13. This
article provides an overview of the molecular biology and microbial
ecology of these communities; a companion paper14 investigates the
stability of features in such data for human population epidemiology. We differentiated 'core' versus variably transcribed functions,
assigned them to specific microorganisms, and assessed differences
between subjects cross-sectionally and within subjects over time.
Finally, ecological co-occurrence and strain diversity were assessed
metagenomically, both remaining strikingly stable over time, and the
latter comparing near-identically between this and an independent
population from the Human Microbiome Project (HMP). Together,
these findings therefore provide an in-depth large-scale exploration
of the human faecal metatranscriptome in a species-specific context.
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gene families by HUMAnN2; of these, 54.8% and 58.1% UniRef90
gene families possessed functional characterization, respectively,
and 10.7% and 13.2% of characterized gene families were assignable
to MetaCyc pathways17. Intriguingly, an average of 69% and 85.4%
UniRef90 relative abundances for metagenomes and metatranscriptomes, respectively, were attributable to gene families lacking biochemical characterization. Stool sample collection, sequence data
generation and quality control are described in Methods.
Prior to investigating the metatranscriptome, we compared the
metagenome-based taxonomic profile of this older cohort to previous population studies (Supplementary Fig. 1), as the mean age

Meta’omic taxonomic and functional profiling. We generated taxonomic and functional profiles of 308 participants’ stool microbiome samples at up to four time points each from DNA (n =  929) and
RNA (n = 372) reads using MetaPhlAn2 (ref. 15) and HUMAnN2
(ref. 16) (Fig. 1; Methods). From the DNA reads, a total of 468
microbial species were detected, with individual samples containing 72 ±  13 (mean ± s.d.) species. HUMAnN2 identified 1,569,171
unique UniRef90 gene families in metagenomes and 602,896 in
metatranscriptomes (Supplementary Table 1). Overall, 75.3% of all
DNA reads and 64.1% of all RNA reads were assignable to UniRef90
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Fig. 1 | Metatranscriptomic and metagenomic taxonomic and functional profile of a prospective human cohort. a, Participants (n =308) from the
MLVS, embedded within the HPFS prospective cohort13, provided a target of four stool samples each. These stool samples were self-collected in 2 pairs,
6 months apart, with each pair spanning 2–3 days. This yielded 929 total metagenomes and 372 metatranscriptomes, sequenced using previously
published protocols9 and functionally profiled using HUMAnN2 (ref. 16). b, To estimate gene family, enzyme class and pathway relative transcription,
RNA abundances were normalized to corresponding DNA abundances. We then evaluated 'core' (prevalently transcribed) and variable transcriptional
elements, in addition to the ecological and phylogenetic diversity of metatranscription and carriage of functional elements among species. EC, Enzyme
Commission number for enzymes. c, Taxonomic profiles were determined using MetaPhlAn2 (ref. 15) from both DNA and RNA data (for RNA viruses).
These were also used for ecological interaction network reconstruction26 with BAnOCC45 (http://huttenhower.sph.harvard.edu/banocc) and for strain
tracking with StrainPhlAn29.
Nature Microbiology | VOL 3 | MARCH 2018 | 356–366 | www.nature.com/naturemicrobiology

© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.

357

Articles

NaTUre MIcrobIology

of our participants was 69 ± 6 years. As in earlier studies with comparable populations and protocols18,19, and in contrast to younger
cohorts with different sample handling methodology3, Firmicutes
were generally prevalent and abundant, in contrast to previous studies of comparable but smaller populations such as ELDERMET19,20
(Supplementary Fig. 2). In addition, a small number of both DNA
and RNA viruses were quantified confidently by MetaPhlAn2,
which is probably an underestimate of the gut virome diversity,
as our extraction protocol did not enrich for virus-like particles.
Although gut viral ecology is more difficult to analyse than that
of the bacteriome owing to inadequate viral reference sequences21,
these methods allow for some incidental analysis of DNA phage
and RNA plant viruses in human faecal metagenomes and metatranscriptomes (see Supplementary Information).
As a first indication of important differences between faecal metagenomic and metatranscriptomic profiles, each sample’s
metatranscriptome contained, on average, 5.4% of the total pool of
gene families observed across the data set; metagenomes averaged
>10% of the pool (Supplementary Table 1). This indicates that, as
in a single organism’s genome, only a subset of faecal functional
potential is active under the circumstances captured by a typical
sample. Technical factors had a minor role in this, as, although
RNA was sequenced at slightly shallower depth (Supplementary
Data set 1), rarefaction indicates that metagenomic taxa, functions and metatranscriptomic functions were well saturated at these
depths (Supplementary Fig. 3). Biological factors seemed to dominate, as transcribed elements should typically be at most those also
observed metagenomically. Ecologically, this is also in agreement
with our previous observation that the metatranscriptome is more
variable than the metagenome9.
Core and variable faecal metatranscriptomes differ from the
metagenome. To identify important pathways expressed (and
not just metagenomically encoded) by microorganisms in the
human gut, we delineated 'core' and 'variable' portions of the faecal metatranscriptome (Fig. 2, Supplementary Data sets 2 and 3).
The former was defined as a set of prevalently transcribed pathways that was robust to sequencing depth and specific prevalence threshold (Supplementary Fig. 4). From 289 pathways
with detectable transcription in at least two samples, 81 (28%)
were core by this definition, 48 of which had a mean DNAnormalized transcript abundance of >1 when transcribed (see
Methods for quantification of metatranscriptional activity). This
was remarkably smaller than a similarly defined core metagenome in this cohort: from 407 pathways with detectable DNA
in at least two samples, 182 (45%) were similarly prevalent, even
though there were almost three-times more metagenomes than
metatranscriptomes. It is noteworthy that neither GC content
nor open reading frame (ORF) length had effects on transcription ratios (see Supplementary Information and Supplementary
Fig. 5). This suggests that gene expression rather than gene abundance underlies qualitative and quantitative differences among
metatranscriptomes.
Unlike the core metagenome, which includes various hostadapted microbial community features3, the core metatranscriptome was enriched mainly for housekeeping functions. Nineteen
nucleotide biosynthesis pathways, 19 glycolysis and carbohydrate
metabolism pathways and 15 amino acid biosynthesis pathways
accounted for the majority of core metatranscribed pathways. Note
that as annotated in MetaCyc, glycolysis represents an umbrella
term that also includes anaerobic fermentation, not an indicator of
aerobic respiration. Glycolysis in this sense had the highest transcript abundance (8.30 ±  5.69 (mean ± s.d.)) and, together with
three nucleotide metabolism pathways, was over-transcribed (relative to DNA abundance) in virtually all metatranscriptome samples
(Fig. 2a,b and Supplementary Fig. 6).
358

Other notable core metatranscriptome pathways included the
non-oxidative pentose phosphate cycle (to support nucleic acid synthesis), breakdown of carboxylates, synthesis of co-factors (folate,
flavin, pantothenate and coeznyme A (CoA)), unsaturated fatty
acids, and microbial recycling of uric acid (the end product of purine
breakdown) to salvage nitrogen. Conversely, cell wall peptidoglycan
and phospholipids, and amino acid synthesis were pathways with
the lowest transcript abundance in the core metatranscriptome.
Interestingly, the core metatranscriptome also included synthesis of
preQ0 (prequeosine-0) and queosine, pleiotropic bacterial metabolites22 that the human host salvages for regulating translational efficiency and fidelity23.
In contrast to the limited core set of metatranscriptomic pathways, the variable metatranscriptome comprised 95 functionally diverse pathways that were well detected in DNA but below
detection in at least half of RNA samples (Fig. 2c); 36 of these
had no detectable RNA in more than two-thirds of the metatranscriptome samples. The bulk of these pathways are involved in
biosynthesis of various amino acids, long fatty acids, terpenoids,
polyamines, co-factors (NAD, haem and tetrapyrolle) and the (p)
ppGpp alarmone24. A smaller number are pathways involved in
the degradation of various alcohols, sugars, formaldehyde and sulfate reduction. Finally, 26 pathways were below detection in most
DNA (and matching RNA) samples. However, when transcribed,
some of these pathways had the highest transcript abundance, for
example, methanogenesis and factor 420 biosynthesis (Fig. 2d and
Supplementary Fig. 6f), suggesting that metagenomically rare but
overtranscribed pathways may be uniquely responsible for subjectspecific gut microbial bioactivity.
Faecal microbiome pathways are transcribed by a limited subset of microorganisms encoding them metagenomically. Using
paired metagenomic and metatranscriptomic functional profiles, we
next assessed the relationship between faecal microorganisms that
tend to carry pathways metagenomically versus those that express
them metatranscriptomically (Fig. 3 and Supplementary Fig. 7).
At a global level, these two aspects of functional diversity corresponded (in large part as only microorganisms carrying a pathway
can express it) with three main groups of pathways that dominate
the functional diversity of these samples. First, housekeeping functions (nucleotide, carbohydrate and amino acid metabolism, among
others) were carried by almost all stool species (high contributional
alpha diversity); they were also actively transcribed by abundant and
prevalent microorganisms, predominantly Bacteroides, Eubacterium
and Ruminococcus spp. (Fig. 3a, bottom cluster). A second pathway
cluster (Fig. 3a, top left) with modest contributional alpha diversity was dominated by Faecalibacterium prausnitzii, a particularly
prevalent organism in this cohort that, when abundant, tended
to contribute the majority of all pathways it encodes (synthesis of
various amino acids, non-oxidative pentose phosphate pathway and
putrescine synthesis, among other pathways). The third, low diversity, cluster (Fig. 3a, top right) was encoded by limited numbers of
opportunists, for example, Escherichia coli, Sutterella, Enterobacter
and Enterococcus spp. This cluster included pathways such as synthesis of the enterobactin siderophore, lipid A and sulfate reduction.
Pyruvate fermentation to acetate and lactate, synthesis of glycogen
and tetrapyrrole were examples of pathways with fairly even metagenomic and metatranscriptomic species contributions. Thus, in summary, the same microorganisms were principal contributors to RNA
and DNA abundances in roughly one-third of pathways. However,
for the majority of pathways, overtranscription was observed
from members of either the Bacteroidetes (mainly for pathways
contributing to active growth in the gut) or the Proteobacteria
(for the subset of generalists pathways upregulated in faeces) relative to the baseline level of metagenomic carriage (for example, by
the Firmicutes).
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Fig. 2 | Core and variable metatranscriptomes of the stool microbiome. DNA-normalized transcript abundances for 239 gut microbiome pathways
with detectable RNA in >10 of the 341 metatranscriptomes, collected from 96 MLVS participants. Samples (columns) were sorted left to right based
on decreasing number of transcribed pathways per sample. a, Core metatranscriptome pathways (transcribed in >80% of samples) with RNA/
DNA transcription ratio of >1. b, Low-expression core metatranscriptome pathways with transcript abundance detectable in >80% of samples but an
RNA/DNA ratio of <1. c,d, Variably metatranscribed pathways detected in DNA but below detection in at least half of RNA samples (c), and variably
metatranscribed pathways below detection in DNA (and matching RNA) in 30–80% of the 341 samples (d). Several pathways representative of functional
categories are annotated, and the complete annotation of all pathway names and definitions are in Supplementary Fig. 6a–d. Thirty-eight pathways that
did not fall into either of the four sections based on these criteria are in Supplementary Fig. 6e. The distribution range of pathways with the overall 30
highest and 30 lowest mean DNA-normalized transcript abundances among the 341 metatranscriptome samples are in Supplementary Fig. 6f. The grey
colour represents pathways that were below detection in both DNA and RNA in a given sample; the black colour represents pathways that were detected
in DNA but below detection in RNA. biosyn., biosynthesis; degrad., degradation; ppGpp, guanosine tetraphosphate; TCA, tricarboxylic acid.

These three major patterns in the functional structure of the
faecal metatranscriptome are explained in greater detail by the
pathways that are most commonly expressed by abundant microorganisms. First, all species shared enrichments for housekeeping
functions (for example, nucleotide synthesis and fermentation,
among others) (Fig. 3b, left columns). A set of anaerobic biosynthesis
pathways were mainly expressed by Firmicutes from the upper left
cluster of the ordination (Fig. 3b, middle columns). Transcription of
cell structure, secondary metabolites and co-factor synthesis pathways was characteristic of Bacteroides spp. (Fig. 3b, right columns).
Finally, the Enterobacteriaceae were not abundant in most subjects,
so few of their pathways were prevalent enough to appear in those
selected for visualization, but the subset of their large pangenome
upregulated in faeces overlapped to a degree with the anaerobic
metabolism expressed by the Firmicutes (Fig. 3b, middle columns).
Many pathways are transcribed by few organisms per community, even when broadly encoded metagenomically. Finally, we
noted that per-microorganism pathway expression is often very

different among individual hosts than is metagenomic pathway carriage, indicating that these two molecular measurements may have
distinct applications in human population studies (Fig. 4). Overall,
metagenomic richness (the number of contributing species) generally exceeded metatranscriptomic richness, as expected. As above, a
subset of pathways were both broadly encoded and expressed (high
diversity), with relatively few differences between individuals, and
these were again mainly housekeeping functions. However, at the
other end of the spectrum, many pathways of greater biochemical
interest were transcribed by only one or a few species, even when
diversely carried metagenomically. An extreme example of low
transcriptional diversity pathways was methanogenesis, encoded
and transcribed solely by Methanobrevibacter smithii; this class of
metatranscriptomic functions may indicate keystone processes and
their associated microorganisms in the gut.
To better understand this phenomenon, and to expand on
our previous observation of basal transcription in a substantial
fraction of gut pathways9, we next identified pathways for which
the transcriptional activities of microorganisms mirrored their
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Fig. 3 | The gut metatranscriptome is personalized and broadly taxonomically distributed. a, Structure of the stool metagenome and metatranscriptome
as contributed by diverse species. Principal coordinates (PCoA) analysis of pathways with microbial species’ contributions to their DNA and RNA
abundances using Bray–Curtis dissimilarity, with a bi-plot overlay indicating centroids of abundant species’ contributions. Thus, each pathway is
denoted by two points, summarizing the organisms contributing them metagenomically (averaged over 913 samples from 307 participants) and
metatranscriptomically (341 samples from 96 participants), and a subset of examples are labelled. The resulting joint ordination indicates broad
agreement between species carrying (metagenomically) and expressing (metatranscriptomically) groups of pathways in the faecal microbiome.
b, Transcription ratios of 30 pathways that were most prevalently transcribed among the top 30 species, using the same data sets as in a. Pathways
for which DNA or RNA were not detected in a given species are grey. A given pathway–species combination in the heatmap represents the transcript
abundance averaged over all samples that measured a non-zero RNA/DNA ratio for that species. Only pathway–species combinations in at least 5
samples (from a total of 341) were considered. Columns in the heatmap were ordered based on average linkage clustering on a Euclidean distance
matrix of log2 pathway transcription ratios. biosyn., biosynthesis; deg., degradation; ferment., fermentation; rns, ribonucleoside; rnt, ribonucleotide; SAM,
S-adenosyl methionine; SP., super pathway. Complete pathway and taxa annotations and abundances can be found in Supplementary Data sets 2 and 3.

metagenomic carriage (Fig. 4b). For this, we used the weighted
mean of the Spearman correlation between taxonomically stratified metagenomic and metatranscriptomic profiles (see Methods).
To emphasize the correlation of the principal species encoding
each pathway, correlation coefficients were weighted by the mean
metagenomic potential of the species. High values indicated that
species-level RNA abundances closely follow DNA abundances,
whereas low values indicated departure from basal expression.
In general, carbohydrate metabolism and nucleotide biosynthesis
particularly tended to be enriched for high correlations, whereas
amino acid biosynthesis was enriched among low correlations.
Low correlations indicate more context-specific, variable expression of the pathway, consistent with the generally amino-acid-rich
environment of the gut. Co-factor biosynthesis pathways were
roughly in the middle of this range, perhaps due to the diversity
of compounds produced with these functions and their variable
availability in the gut. For example, pantothenate is found in most
foods and is easily salvaged from the gut environment, whereas
folate transformations are critical for one-carbon (C1) metabolism25, making this pathway more widely transcribed when present
in species.
Notably, pathways with similar metagenomic contributions were
not necessarily similarly transcribed (Fig. 4c,d). Core pathways were
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both metagenomically and metatranscriptomically diverse, carried
and expressed by many organisms per community (Fig. 4d and
Supplementary Fig. 8). However, typical variable pathways, even
when broadly distributed metagenomically, were often transcribed
by one or few organisms per individual. Transcribing organisms
were often neither the most abundant nor the same species across
individuals (Fig. 4c). Similar patterns were observed for l-isoleucine
biosynthesis III (PWY-5103), l-tryptophan biosynthesis (TRPSYNPWY), degradation of various sugars (stachyose (PWY-6527),
sucrose (PWY-621), rhamnose (RHAMCAT−PWY)), non-oxidative pentose phosphate pathway, preQ0 biosynthesis (PWY−6703),
and others (Supplementary Fig. 8). This finding highlights another
aspect of inter-individual diversity in the microbiome: different
microorganisms may activate shared pathways among individuals,
with as-yet-unknown functional specializations and consequences.
Inter-microbial species interactions are stable in the stool ecosystem of older men. To leverage this cohort’s taxonomic profiles independently of their metatranscriptomes, we also inferred
metagenomic microbial interaction networks26 using the Bayesian
Analysis of Compositional Covariance (BAnOCC) framework (see
Methods; Fig. 5 and Supplementary Fig. 9). We generated one network per time point, allowing the stability of co-occurrence and
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Fig. 4 | Transcriptional landscape of the stool microbiome. a, Distributions of alpha diversity (Gini–Simpson index) for the species-specific metagenomic
and metatranscriptomic contributions to each pathway, for 70 non-redundant pathways with the highest community-level RNA abundances, averaged
across 341 metatranscriptomes from 96 participants. Pathways were sorted by the sum of the median metagenomic alpha diversity and the weighted
Spearman correlation from b. Boxplot whiskers represent 1.5 times the interquartile range from the first and third quartiles. b, Concordance of metagenomic
potential with metatranscriptomic activity (metagenome-weighted mean of per-species Spearman correlations; see Methods). Metatranscriptomic
diversity is, as expected, consistently lower than metagenomes, with pathways carried by only a few organisms that are also more differentially transcribed;
dns, deoxyribonucleosides. See caption of Fig. 3 for definitions. c,d, Metagenomic potential (bottom) and metatranscriptomic activity (top), for example,
contribute pathways with differing ecological structure, specifically GDP-mannose biosynthesis (PWY-5659) (c) and adenosine ribonucleotide de novo
biosynthesis (PWY-7219) (d). Abundances were normalized within each pathway for 189 subject–week pairs, from 96 participants. Subjects (columns) were
ordered to emphasize blocks of subjects with similar metatranscriptomic profiles (see Methods). The top 8 (c) and top 15 (d) species, in terms of their
mean metatranscriptomic contribution to the pathways in c and d, are shown for clarity. Examples show transcriptional ecologies that either differ strikingly
from c or generally mirror d in their metagenomic diversity. Pathway definitions on the x axis of panel b were truncated for space; full definitions can be
found in Supplementary Data sets 2 and 3, as well as on www.metacyc.org by searching for pathway names, for example PWY-7219.

co-exclusion relationships to be determined. Negative associations
between Bacteroides spp. and Ruminococcaceae or Prevotellaceae
observed previously26 were not recapitulated in this population, and

Firmicutes species predominantly co-occurred with other members of the phylum. This is consistent with the observation that cooccurrence/co-exclusion among microbial community members
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Fig. 5 | Ecological interactions in the gut microbiome. Significant co-variation and co-exclusion relationships among 104 species in 913 stool
metagenomes from 307 MLVS participants. Each node represents a species and edges correspond to significant interactions inferred by BAnOCC (see
Methods). Stool microbiome taxonomic profiles were averaged within each subject for the first and second collection pairs (separated by 6 months).
Interactions in at least one time point are included here. No alternating associations (positive at one time and negative in another) were detected.
Ninety-five per cent credible interval criteria were used to assess significance and only estimated absolute correlations with effect sizes of ≥0.15 are
reported. Networks for individual time points are shown in Supplementary Fig. 9. Complete taxonomic profiles for all stool metagenomes can be found in
Supplementary Table 3.

is not based solely on phylogenetic relatedness, but also on how
microorganisms complement each other functionally27.
Genetic divergence patterns of stool-associated bacterial strains
are species-specific and preserved among host populations.
Finally, we assessed strain-level variation in stool bacterial populations using StrainPhlAn (see Methods) and provided a comparison
of species population structure between the MLVS and the HMP3,28
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cohorts (Fig. 6). Twenty-one species had sufficient genomic coverage for reliable strain identification from metagenomes in both
cohorts. Eubacterium siraeum, for example, demonstrated discrete
strain clustering indicative of a clonal population, with strains from
the same individual remaining near-identical over the sampling
period. Conversely, nucleotide variation among F. prausnitzii strains
did not reveal a discernible pattern, and was characterized by the
highest median and widest range of nucleotide substitution rates,
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Fig. 6 | Species-specific patterns of evolutionary divergence within species preserved across cohorts. a,b, Panels show strain-level diversity within
Eubacterium siraeum (a) and F. prausnitzii (b). Each point represents one sample’s strain, ordinated by PCoA of sequence dissimilarity (Kimura twoparameter distance). c, Pairwise nucleotide substitution rates within and between cohorts for 21 out of 30 species in Fig. 3 with sufficient prevalence in
both cohorts for informative comparison. The rate of nucleotide divergence between the MLVS and HMP cohorts are summarized with the 'Between'
boxplots for each species. Lines represent median values, points denote outliers outside 1.5 times the interquartile range. All numbers in parentheses
are sample counts in which indicated strains were above the limit of detection, from a total of 913 MLVS stool metagenomes and 553 HMP stool
metagenomes (from 253 male and female HMP participants) that were analysed with StrainPhlAn. SNPs, single-nucleotide polymorphisms.

consistent with extreme genomic diversity whereby each strain can
be substantially distinct from another. Several species, including
Bacteroides stercoris, Bacteroides uniformis and Butyrivibrio crossotus, presented an intermediate structure with weak clonal propagation of a potential outgroup (Supplementary Fig. 10).
Remarkably, nucleotide substitution rates were near-identical
between the two unrelated cohorts (Fig. 6c). The average ratio of
between-cohort to within-microorganism divergence was 1.0 ±  0.03
(mean ± s.d.), indicating that bacterial population structure is consistent across host populations. Previous studies have shown that
human gut microorganisms can diverge between geographically
and genetically distinct host populations29. However, the existence
of such closely related microbial strains between independent
North American cohorts with very different age ranges (18–40
versus 65–81 yr) suggests that specific microbial strains (or related
strain groups) may be a useful, stable feature to assay during epidemiological studies.

Discussion

The present study has provided an overview of the faecal metatranscriptome in a prospective, large-scale cohort of elderly males; identified core and variably transcribed pathways; delineated how these
differ from metagenomic functional potential; and ascribed them
to specific contributing organisms. Finally, paired metagenomes in
this study also allowed species-specific ecological interaction networks to be reconstructed, which proved stable over time, as did
strain tracking within species. This stability, in combination with
the commonality of strain-level microbial population structures
between cohorts, suggests that they might represent particularly
effective measurement targets for the microbiome in population
studies. Together, these findings extend our earlier pilot study in
eight individuals9 and accompany epidemiological work14 to integrate metatranscriptomics into population studies.
It is evident from our results that the metatranscriptome is more
temporally dynamic, context-sensitive and species-specific than
the metagenome. The observed incongruence between species
abundance and transcriptional activity agrees with an earlier study

of taxa–function relationships in the human faecal metatranscriptome30. This is expected, as transcription is a highly variable process
even among cells of the same species under steady-state conditions31. However, heterogeneity among species’ transcriptional contributions in otherwise similar metagenomes may be influenced by
many factors, including nutrient availability, preferential utilization
or xenobiotics; temporal differences in environmental sensing that
stagger response to stimuli among species; and metabolic dependence that drives cross-feeding of intermediate metabolites through
community members32,33. This extends the typical model of transcriptional behaviour from individual microbial or metazoan cell
populations to niche ecology.
A feature of the metatranscriptome, which is critical for human
microbiome population studies, was the propensity of different
organisms to appear as primary transcribers of pathways between
individuals. In relating metagenomic features to the metatranscriptome, we observed only 44% of the 'core' metagenomic potential
(81 transcribed pathways out of 182 prevalent metagenomically) to
be transcribed in the cohort. In combination with previous studies of 'core' metagenomics18,34,35, this suggests a functional ecological model in which a prevalent metagenome encoding substantial
redundancy is distributed among many microorganisms per individual, with the microorganisms containing this core varying
among hosts. Transcription at any one time or in any given environment is then typically dominated by one or a few members. This
model of microbial ecology would be analogous to silencing versus
upregulation of distinct portions of the human genome among cell
types, which also consists of a 'core' underlying DNA genome with
long-term (epigenetics, instead of phylogeny) and short-term (transcriptional) regulatory mechanisms36.
In addition to these insights into metatranscriptional activity,
stool taxonomic profiles in the MLVS cohort remained diverse and
stable, which is in agreement with previous studies of the microbiome in elderly individuals20. However, few profiles of this unique
ecosystem have yet been generated, and those that do exist tend to
use widely varied technical characteristics and study design, prohibiting direct comparisons. ELDERMET37, for example, posited
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a trend towards Bacteroidetes dominance in ageing, but this replicated neither across technologies within this cohort nor in our
MLVS data. As MLVS data are drawn from within the broader
HPFS, for which several decades of dietary and environmental
data are available, we anticipate that future studies focusing on
these detailed metadata will further detail microbial links to lifestyle and nutrition.
A challenge going forward will thus be to identify epidemiological contexts in which metatranscriptomic features are specifically
informative, and the appropriate ways in which to measure them.
This might include, for example, tests for health outcomes that are
predicted uniquely by metagenomic activities. These may, based on
this study’s results, be functionally consistent but contributed by
different microorganisms across individuals, even when not differentially represented in underlying metagenomes. It also remains to
associate metatranscriptomic responses with detailed information
on immediate lifestyle exposures, such as recent diet, to determine
temporal responses of the metatranscriptome to key environmental perturbations. Ultimately, if there are health outcomes for which
causal molecular mechanisms are uniquely detectable in the faecal
metatranscriptome, its functional profile will need to be better characterized and integrated as a measurement in human epidemiological population studies.

Methods

MLVS cohort, stool sample collection, shotgun sequencing and quality
control. The HPFS is a prospective cohort study aimed at investigating the
determinants of men’s health, into which 51,529 US men aged 40–75 yr were
recruited in 1986 and subsequently followed biennially13. For this analysis, we
used data from a sub-study of the HPFS, the MLVS, in which 308 participants
provided up to two pairs each of self-collected stool samples from consecutive
bowel movements, during 2012. The second pair of samples was collected
approximately 6 months after the first. The median time between consecutive
bowel movements for a pair of samples was 48 h; collection dates are in
Supplementary Table 2. At the time of collection, the age of participants ranged
between 65 and 81 yr. Cohort details, sample collection and immediate ex situ
conservation of metagenomic and metatranscriptomic components, laboratory
handling, and paired-end (100 × 100 nucleotides (nt)) shotgun sequencing of
RNA and DNA are detailed in the companion manuscript14 and in our pilot
study9, respectively. Study protocol 22067–102 titled “Men’s Lifestyle Validation
Study and Microbiome Correlation” was approved by the Harvard Chan School
of Public Health Institutional Review Board, and informed consent was obtained
from all participants.
The gut microbiome, as captured by stool, was sampled from 308 male
participants (aged 65–81 yr) within the MLVS sub-cohort of the HPFS (Fig. 1).
Each participant provided up to two pairs of self-collected stool samples from
consecutive bowel movements; with the second pair of samples collected
approximately 6 months after the first. DNA was extracted from all 929
resulting samples, in addition to RNA from a subset of 372 samples spanning 96
participants. Illumina HiSeq sequencing yielded a total of 4.5 Tera nt of paired-end
reads (100 × 100 nt). This included an average of 3.8 Gnt ± 1.5 Gnt (mean ±  s.d.
Giga nt) before quality filtering (see below) and 1.9 Gnt ± 0.7 Gnt afterward per
metagenome, and 3.0 Gnt ± 2.4 Gnt and 1.3 Gnt ± 1.0 Gnt before and after quality
control for metatranscriptomes, respectively. Forty-one samples (16 DNA and
25 RNA) had <1 million reads after quality filtering and were excluded from
further analysis. Thus, the final data sets analysed comprised 913 metagenomes
and 347 metatranscriptomes.
Taxonomic and functional profiling of metagenomic and metatranscriptomic
samples. Sequence reads were passed through the KneadData v0.3 quality control
pipeline (http://huttenhower.sph.harvard.edu/kneaddata), which incorporates
the Trimmomatic38 and BMTagger39 filtering and decontamination algorithms
to remove low-quality read bases (thresholding Phred quality score at <20)
and remove reads of human origin, respectively. Trimmed non-human reads
shorter than 70 nt were discarded. Taxonomic profiling was performed using the
MetaPhlAn2 classifier15, which relies on approximately 1 million clade-specific
marker genes derived from 17,000 microbial genomes (corresponding to
>7,500 bacterial, viral, archaeal and eukaryotic species) to unambiguously classify
metagenomic reads to taxonomies and yield relative abundances of taxa identified
in the sample. We quality-controlled taxonomic profiles by requiring at least 10%
of clade-specific markers to recruit at least 1 read per kilobase (RPK) for inclusion
in subsequent analyses. In addition to DNA, RNA (complementary DNA (cDNA))
reads were also analysed with MetaPhlAn2 to quantify RNA viruses.
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Metagenomes and metatranscriptomes were functionally profiled using
HUMAnN2 (ref. 16) to quantify genes and pathways (http://huttenhower.
sph.harvard.edu/humann2). Briefly, for each sample, taxonomic profiling is
used to identify detectable organisms. Reads are recruited to sample-specific
pangenomes, including all gene families in any detected microorganisms using
Bowtie2 (ref. 40). Unmapped reads are aligned against UniRef90 (ref. 41)
using DIAMOND translated search42. Hits are counted per gene family and
normalized for length and alignment quality. For calculating abundances
from reads that map to more than one reference sequence, search hits are
weighted by significance (alignment quality, gene length and gene coverage).
UniRef90 abundances from both the nucleotide and protein levels were then
(1) mapped to level 4 EC nomenclature, and (2) combined into structured
pathways from MetaCyc17. We used the MinPath43 and gap filling options in
HUMAnN2 version 0.8.0. For the purposes of functional profiling, each read
can be (1) mapped to a specific organism’s characterized gene family in one or
more known pathways, (2) mapped to a characterized protein family (without
assignment to a specific organism), (3) mapped to an uncharacterized gene
family (not in any pathway), or (4) not mapped to any gene family. HUMAnN2
refers to these as (1) species-specific, (2) unclassified, (3) unintegrated, and (4)
unmapped reads, respectively. Per sample breakdown of HUMAnN2 mapping
categories (that is, mapped, unclassified, unintegrated and unmapped RPKs)
are provided in Supplementary Data set 5. Reads that mapped only at the amino
acid level are not used when calculating specific taxa’s functional contributions.
Instead, only reads that mapped (unambiguously) at the nucleotide level are
included in these totals.
Quantification of metatranscriptomic functional activity. Metatranscriptomic
functional activity was assessed in the 341 samples with both RNA and DNA
data in a manner not unlike two-channel microarrays using RNA/DNA
ratios (see RNA/DNA normalization below). Owing to the compositionality
of RNA and DNA measurements, the resulting ratio is relative to the mean
transcript abundance of the entire microbial community. That is, a ratio of 1
implies that the pathway is transcribed at the mean transcription abundance
of all pathways in the microbial community. These quotients of RNA/DNA
feature abundances allowed unbiased comparison of transcript abundances of
metagenomic features between samples and also provided a comparative index
of over/undertranscription (relative to DNA copy number) within individual
microbiome samples. Pathways that had <1 RPK of either RNA or DNA were
treated as not detected in the analyses.
RNA/DNA normalization. Metatranscriptomic features (that is, RNA abundances
of genes, enzymes and pathways) were normalized to corresponding metagenomic
features to obtain an estimate of the mean transcription abundance λ as follows:
λf ,i =

(

R f , iH R f , i− t

∑i

R f ,i

)×

∑i Df ,i

(

Df , iH Df , i−t

)

Rf,i and Df,i are the counts, in RPK, of feature f in sample i, for the
metatranscriptome and metagenome respectively. H(x) is a unit step function
with threshold x, and t is the detection threshold, here set to 1 RPK. This
threshold ensures that RNA and DNA abundances that are confidently quantified
(>1 RPK) are included, reducing the effect of increased noise due to genes and
transcripts with low sequencing coverage. Summary statistics and analyses were
only performed where both the numerator and denominator are measurable,
although such gene families were tracked in RNA or DNA alone, respectively.
Note that a value λf,i = 1 does not imply that the feature has an equal number of
copies in RNA as it does in DNA. Rather, it implies that the mean transcription
abundance is equal to the global mean transcription abundance of all organisms
in the community in sample i. Thus, λf,i > 1 implies a transcript abundance above
the community mean, which may be different in different samples.
EC dispersion. Co-expression of functionally related ECs was quantified by the
mean variance of the standardized EC expression log-ratios for the set of ECs
contributing to a given pathway. Specifically:
1
N

N

∑
i =1

1
P −1

∑ (zc,i−z∙,i)2 , zc,i =
c ∈P

xc, i−x∙, i
Var[xc, i]

where xc,i is the expression log-ratio for EC c in sample i, P is a given pathway, 〈•〉
represents the mean, and Var[●] represents the variance. When the expression
of functionally related ECs is not related (that is, uncorrelated), then this value is
expected to be 1. Lower values indicate the presence of co-expression of ECs, with 0
indicating a perfect relationship.
Species-specific meta’omic concordance. Concordance between species-level
metagenomic and metatranscriptomic pathway abundances was assessed using
the mean of the Spearman correlation, weighted by the mean metagenomic
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contribution of each species to the overall pathway abundance. After averaging
across multiple samples per subject, we calculated:
WSpear(p) =

∑s Spearman(dp,s,∙, rp,s,∙) ∑i dp,s,i
∑s ∑i dp,s,i

where dp,s,i and rp,s,i are the relative abundances of pathway p, contributed by
species s in sample i in DNA and RNA, respectively. Spearman is the Spearman
correlation between two vectors, where ties are given the mean rank of the tied
values, and defined to be 0 when either vector has no variance. This weighting
downweights the concordance for species that do not contribute much of the
pathway’s abundance, mitigating the uncertainty inherent in estimating transcript
abundances of low-abundance species and genes.
Microbial ecology networks. Ecological covariation was assessed using BAnOCC,
a Bayesian model for detecting significant pairwise associations in compositional
data26 (http://huttenhower.sph.harvard.edu/banocc). Briefly, BAnOCC models
the sequence generation process using a log-normal distribution on unobserved
absolute counts, and constrains the associated correlation matrix through a
sparsity-inducing prior. For posterior inference, we use the 95% credible interval,
that is, a correlation estimate is considered significant if the corresponding
95% credible interval excludes zero. We estimated ecological networks for the
two sampling time points independently, from within-subject means of species
abundance profiles, and then overlaid the networks to assess similarities and
differences between networks over the length of the sampling period.
Inference of strain-level population structure. Strain profiling was carried out
using StrainPhlAn v1.0 (ref. 29) (http://segatalab.cibio.unitn.it/tools/strainphlan).
Briefly, after mapping reads to MetaPhlAn2 species-specific markers for
sufficiently abundant species in each sample, a per-sample consensus sequence
is built for each marker. For each species, these are concatenated, aligned, and
variants identified relative to reference. Here, pairwise evolutionary distances
were calculated from these variant alignments, with the Kimura two-parameter
distance44 for ordination analysis using R packages vegan and ggplot2.
Structure of the stool metagenome and metatranscriptome as contributed by
diverse species. The input for the joint ordination of pathways and species (Fig. 3a)
was the pathway genomic and transcriptional abundance of known taxonomic
provenance only, averaged over 913 metagenomes and 341 metatranscriptomes.
Species contributing <1.0 ⨯  10–7 metagenomic relative abundance to a pathway
in <5% of pathways were removed, and the same criteria were used to remove
metagenomic pathways found in species. Out of 339 species that were found to
contribute to 219 pathways, 223 (65.8%) species and 109 (34.2%) pathways satisfied
the filtering criteria. The metatranscriptome pathway by species matrix was subset to
the same 109 pathways as for metagenomes, which were contributed by 194 species,
and merged with the DNA pathway by species matrices into a single input matrix.
Life Sciences Reporting Summary. Further information on experimental design is
available in the Life Sciences Reporting Summary.
Data availability. Sequence data have been deposited in the Sequence Read
Archive under BioProject accession PRJNA354235. Data from the HPFS, including
metadata not included in the current manuscript but collected as part of the MLVS,
can be obtained through written application. As per standard controlled access
procedure, applications to use HPFS resources will be reviewed by our External
Collaborators Committee for scientific aims, evaluation of the fit of the data for the
proposed methodology, and verification that the proposed use meets the guidelines
of the Ethics and Governance Framework and the consent that was provided by the
participants. Investigators wishing to use the HFPS/MLVS cohort data are asked
to submit a brief (2 pages) description of the proposed project ('letter of intent') to
Eric Rimm, HPFS Director (erimm@hsph.harvard.edu).
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Experimental design

1. Sample size
Describe how sample size was determined.

The cohort was pre-existing, detailed in citation 13{PMID:18005960} of the
manuscript.
The Health Professionals Follow-up Study (HPFS) is an ongoing prospective cohort
study which began in 1986 among 51,529 US male podiatrists, dentists,
osteopathic physicians, veterinarians, pharmacists, and optometrists aged 40 to 75
years at enrollment. In this study, participants have returned questionnaires every
two to four years with greater than 90% follow-up to provide information about
lifestyle and dietary factors, medication use, and diagnoses of colorectal cancer
and other diseases. The Men’s Lifestyle Validation Study (MLVS) was established
among 700 men aged 52 to 81 years (median 69 years) nested within HPFS who
had completed the 2010 food frequency questionnaire and previously provided a
blood sample.
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Corresponding author(s): Andrew Chan & Curtis Huttenhower

2. Data exclusions
Describe any data exclusions.

Men with coronary artery disease, stroke/TIA, cancer (except squamous or basal
cell skin cancer), or major neurological disease (ALS, Alzheimer’s, Parkinson’s,
epilepsy, MS) were excluded.
Sequencing data was excluded if samples had insufficient input material after DNA/
RNA extraction or with insufficient sequencing depth (<2 million reads) after
sequencing.

3. Replication
Describe whether the experimental findings were
reliably reproduced.

Sample collection and data generation was validated in a previous study (Franzosa
et al., Relating the metatranscriptome and metagenome of the human gut, PNAS
2014). All code for the taxonomic and functional analysis has been validated and is
publicly available (see Methods section for details).

4. Randomization
Describe how samples/organisms/participants were
allocated into experimental groups.

Patients were consented prior to a screening colonoscopy, which separated them
into confirmed IBD patients and non-IBD controls.

5. Blinding
Describe whether the investigators were blinded to
group allocation during data collection and/or analysis.

Blinding was not used for the data collection and analysis.

Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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6. Statistical parameters

n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the
Methods section if additional space is needed).

Software

Policy information about availability of computer code

7. Software
Describe the software used to analyze the data in this
study.

Sequence reads were processed with the KneadData v0.5.1 quality control (QC)
pipeline. Taxonomic profiling was performed using the MetaPhlAn2 classifier.
Functional profiling of metagenomes and metatranscriptomes was performed
using HUMAnN2. Details are provided in the methods section of the manuscript.

For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for
providing algorithms and software for publication provides further information on this topic.
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Materials and reagents

Policy information about availability of materials

8. Materials availability
Indicate whether there are restrictions on availability of
unique materials or if these materials are only available
for distribution by a for-profit company.

No unique materials were used.

9. Antibodies
Describe the antibodies used and how they were validated Not applicable.
for use in the system under study (i.e. assay and species).

10. Eukaryotic cell lines
Not applicable.

b. Describe the method of cell line authentication used.

Not applicable.

c. Report whether the cell lines were tested for
mycoplasma contamination.

Not applicable.

d. If any of the cell lines used are listed in the database
of commonly misidentified cell lines maintained by
ICLAC, provide a scientific rationale for their use.

Not applicable.
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a. State the source of each eukaryotic cell line used.
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Animals and human research participants

Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines

11. Description of research animals
Provide details on animals and/or animal-derived
materials used in the study.

No research animals were used in this study.

Policy information about studies involving human research participants

12. Description of human research participants
Describe the covariate-relevant population
characteristics of the human research participants.

The Men’s Lifestyle Validation Study (MLVS) was established among 700 men aged
52 to 81 years (median 69 years) nested within HPFS who had completed the 2010
food frequency questionnaire and previously provided a blood sample.
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